SDG Focus Points For The G20 Health and Development Partnership

Realising that globally we must unite and scale-up our efforts to accelerate the end of communicable diseases should be on top of the global agenda. We won’t settle for less.
Join our session @WorldHealthSmt in Berlin on October 27 at 2:00 pm. You can check speakers 👇

At #UNGA we met w @PeterASands who supported our G20 report calling for the use of innovative financing models for innovation in health. Today, we support the opening of the @GlobalFund 6th Replenishment #Lyon .We encourage everyone to #StepUpTheFight against HIV, TB, Malaria!

Partnership works: Without #innovations supported & led by @GlobalFund & Unitaid, it would take 3 extra years for the Global Fund to achieve its intended impact. See our video: "Success is when innovations reach those in need" #StepUpTheFight

Great discussions at the High Level Meeting on Innovative Financing with Minister @moteging @JBLemoyne @T_Drame @AkselJakobsen3 and @CharlottePetriG @NickDyerDFID on how to achieve the SDGs and how to close the annual funding gap of 2.5 - 3 trillion USD #UNGA #innovate4health

Load More...

Better Health
For everyone

By the late 1990s, studying developing country needs, the Global Forum for Health Research adopted the term “the10/90” gap to call attention to the fact less than 10% of the worldwide resources devoted to health were put towards health in developing countries, where more than…
Read more

Health Innovation
For everyone

Differences in access to health innovations have always existed. Market forces and government engagement have not been great enough to ensure that these innovative goods are made accessible when and where they are needed, most particularly in the developing countries. 
Read more

Inclusive Partnerships
For everyone

A successful sustainable development agenda requires inclusive partnerships between governments, the private sector and civil society at the global, regional, national and local level that are built upon principles and values, a shared vision, and shared goals placing people…
Read more

Innovative Funding for Health
For everyone

There is a dramatic shortfall in current resources needed to achieve sustained progress in health to meet Goal 3 of the United Nations Sustainable Development Goals (SDG3). While infectious diseases are a major health risk in the lower-income countries, the burden of…
Read more
Professor David L. Heymann

Healthy Nations. Sustainable Economies.

How innovation can better ensure health for all.

This report by the G20 Health and Development Partnership sets out to support the need to invest in human capital in terms of global health. It is a holistic approach that blends economies and health so that wealth and the health of nations are united in a new priority for government, society and the economic actors in the rest of the century.

Lord Jim O'NeillChair, Royal Institute of International Affairs Chatham House London
Find out more

“It is important to highlight that the treatment of issues such as antimicrobial resistance and the financing of universal health coverage are issues present today in all international health forums and represent a danger to economic stability as a whole.” (G20 Argentina 2018)

The G20 Health & Development Partnership (G20 HDP) is an advocacy organisation that aims to ensure that G20 countries are coordinating their health innovation strategy to tackle the growing burden of communicable and non-communicable diseases globally to promote the delivery of SDG 3. The Partnership emerged as an informal coalition of like-minded organisations during the G20 Presidency in Germany in 2017 respecting the objectives of SDG 17. Following broad interest to build on the initiative leading up to the Argentinian G20 Presidency in 2018, Sovereign Sustainability and Development (SSD) was created in late 2017 to act as the secretariat of the Partnership. During a working session in the UK Houses of Parliament in December 2017, with the support of the founding organisations, the G20 HDP was formally launched. The Partnership comprises of 16 cross-sectoral partners including product development partnerships, non-for-profit and international organisations, public-private partnerships, pharmaceuticals, associations, research institutes and academia.

Following the Health20 event in the sidelines of the World Health Assembly in Geneva, the G20 HDP has jointly drafted several recommendations in a Report in which the Partnership urged the G20 Heads of Government, Health and Finance Ministers to incentivise innovation in health research and development (R&D) and delivery.

Read more

Keep up to date with our latest News